Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
21 March 2014Website:
http://www.pulmatrix.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Thu, 27 Jun 2024 20:04:12 GMTDividend
Analysts recommendations
Institutional Ownership
PULM Latest News
Cross license involves Pulmatrix iSPERSE™ technology and MannKind's Cricket® inhalation device. Pulmatrix transferring leased building, all leasehold improvements, laboratory equipment and other related personal property in exchange for MannKind assumption of lease.
What type of business is Pulmatrix?
Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing Pulmazole, an inhaled anti-fungal drug for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma, and in patients with cystic fibrosis; PUR1800, a narrow spectrum kinase inhibitor that is in Phase 1b clinical trials for patients with stable moderate-severe chronic obstructive pulmonary disease; and PUR3100, an iSPERSE formulation of dihydroergotamine for the treatment of acute migraine. The company has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates; a development and commercialization agreement with Cipla Technologies LLC for the development and commercialization of Pulmazole; and a collaboration and license agreement with Sensory Cloud, Inc. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts.
What sector is Pulmatrix in?
Pulmatrix is in the Healthcare sector
What industry is Pulmatrix in?
Pulmatrix is in the Biotechnology industry
What country is Pulmatrix from?
Pulmatrix is headquartered in United States
When did Pulmatrix go public?
Pulmatrix initial public offering (IPO) was on 21 March 2014
What is Pulmatrix website?
https://www.pulmatrix.com
Is Pulmatrix in the S&P 500?
No, Pulmatrix is not included in the S&P 500 index
Is Pulmatrix in the NASDAQ 100?
No, Pulmatrix is not included in the NASDAQ 100 index
Is Pulmatrix in the Dow Jones?
No, Pulmatrix is not included in the Dow Jones index
When does Pulmatrix report earnings?
The next expected earnings date for Pulmatrix is 09 August 2024